Table of Contents Author Guidelines Submit a Manuscript
Journal of Toxicology
Volume 2015, Article ID 535490, 6 pages
http://dx.doi.org/10.1155/2015/535490
Research Article

Evaluation of Possible Genotoxic Activity of Dirithromycin in Cultured Human Lymphocytes

1Department of Biology, Science and Arts Faculty, Kahramanmaraş Sütçü İmam University, Kahramanmaraş, Turkey
2Department of Biology, Science and Arts Faculty, Mustafa Kemal University, Antakya, Turkey

Received 13 July 2015; Accepted 7 October 2015

Academic Editor: Orish Ebere Orisakwe

Copyright © 2015 Ahmet Kayraldız et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. M. Wintermeyer, S. M. Abdel-Rahman, and M. C. Nahata, “Dirithromycin: a new macrolide,” Annals of Pharmacotherapy, vol. 30, no. 10, pp. 1141–1149, 1996. View at Google Scholar · View at Scopus
  2. R. Jain and L. H. Danziger, “The macrolide antibiotics: a pharmacokinetic and pharmacodynamic overview,” Current Pharmaceutical Design, vol. 10, no. 25, pp. 3045–3053, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Mazzei, E. Mini, A. Novelli, and P. Periti, “Chemistry and mode of action of macrolides,” Journal of Antimicrobial Chemotherapy, vol. 31, pp. 1–9, 1993. View at Google Scholar
  4. S. Omura, Macrolide Antibiotics: Chemistry, Biology, and Practise, Elsevier, San Diego, Calif, USA, 2nd edition, 2002.
  5. G. D. Sides, B. J. Cerimele, H. R. Black, U. Busch, and K. A. Desante, “Pharmacokinetics of dirithromycin,” Journal of Antimicrobial Chemotherapy, vol. 31, supplement C, pp. 65–75, 1993. View at Publisher · View at Google Scholar
  6. W. Schönfeld and H. A. Kirst, Macrolide Antibiotics, Birkhauser, Berlin, Germany, 2002.
  7. G. Brambilla, F. Mattioli, L. Robbiano, and A. Martelli, “Studies on genotoxicity and carcinogenicity of antibacterial, antiviral, antimalarial and antifungal drugs,” Mutagenesis, vol. 27, no. 4, pp. 387–413, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Brambilla and A. Martelli, “Update on genotoxicity and carcinogenicity testing of 472 marketed pharmaceuticals,” Mutation Research/Reviews in Mutation Research, vol. 681, no. 2-3, pp. 209–229, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Donbak, E. Rencuzogullari, A. Yavuz, and M. Topaktas, “The genotoxic risk of underground coal miners from Turkey,” Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol. 588, no. 2, pp. 82–87, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Speit and S. Haupter, “On the mechanism of differential giemsa staining of bromodeoxyuridine-substituted chromosomes. II. Differences between the demonstration of sister chromatid differentiation and replication patterns,” Human Genetics, vol. 70, no. 2, pp. 126–129, 1985. View at Google Scholar · View at Scopus
  11. M. Fenech, “The in vitro micronucleus technique,” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 455, no. 1-2, pp. 81–95, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Guo, Y. Cai, D. Chai, B. Liang, N. Bai, and R. Wang, “The cardiotoxicity of macrolides: a systematic review,” Pharmazie, vol. 65, no. 9, pp. 631–640, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Periti, T. Mazzei, E. Mini, and A. Novelli, “Adverse effects of macrolide antibacterials,” Drug Safety, vol. 9, no. 5, pp. 346–364, 1993. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Araújo and P. Demoly, “Macrolides allergy,” Current Pharmaceutical Design, vol. 14, no. 27, pp. 2840–2862, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. J. G. Stine and J. H. Lewis, “Hepatotoxicity of antibiotics: a review and update for the clinician,” Clinics in Liver Disease, vol. 17, no. 4, pp. 609–642, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. A. K. Karabulut, I. I. Uysal, H. Acar, and Z. Fazliogullari, “Investigation of developmental toxicity and teratogenicity of macrolide antibiotics in cultured rat embryos,” Anatomia, Histologia, Embryologia, vol. 37, no. 5, pp. 369–375, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. H. B. İla and M. Topaktaş, “In vivo genotoxic effects of spiramycin in rat bone marrow cells,” Cytologia, vol. 64, no. 3, pp. 277–283, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Rocco, C. Peluso, and V. Stingo, “Micronucleus test and comet assay for the evaluation of zebrafish genomic damage induced by erythromycin and lincomycin,” Environmental Toxicology, vol. 27, no. 10, pp. 598–604, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Rencüzoğulları, H. B. İla, M. Topaktaş, A. Kayraldız, S. Budak, and M. Arslan, “No significant increase in chromosome aberrations and sister chromatid exchanges in cultured human lymphocytes treated with spiramycin,” Teratogenesis, Carcinogenesis, and Mutagenesis, vol. 22, no. 1, pp. 51–58, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Q. Guo and Z. H. Yuan, “Mutagenicity test of eight antibiotics with the Ames method,” Chinese Journal of Antibiotics, vol. 10, no. 2, pp. 56–59, 1985. View at Google Scholar
  21. S. Agüloğlu and C. Ortakaya, “Eritromysinin insan kromozomları üzerine in vitro etkileri,” in XI Ulusal Biyoloji Kongresi, Genel Biyoloji, pp. 33–43, Elazığ, Turkey, June 1992.
  22. D. Grujičič, I. Stošić, and O. Milošević-Djordjević, “The antibiotic erythromycin did not affect micronucleus frequency in human PHA-stimulated lymphocytes,” Archives of Biological Sciences, vol. 61, no. 2, pp. 179–185, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Grujičić, O. M. Djordjevic, S. Arsenijević, and D. Marinković, “The effect of combined therapy with ritodrine, erythromycin and verapamil on the frequency of micronuclei in peripheral blood lymphocytes of pregnant women,” Clinical & Experimental Medicine, vol. 7, no. 1, pp. 11–15, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. A. A. Tohamy, “Genotoxicity induced by drug-drug interaction between the antidepressant sertraline and the antibiotic erythromycin in mice bone marrow cells,” The Egyptian Journal of Hospital Medicine, vol. 22, no. 1, pp. 139–145, 2006. View at Google Scholar
  25. F. Hirano and U. Takeda, “Evaluation of the mutagenicity of miokamycin (MOM), a new macrolide antibiotic in the Ames Salmonella test and the dominant lethal assay,” The Journal of Antibiotics, vol. 34, no. 4, pp. 443–446, 1981. View at Publisher · View at Google Scholar · View at Scopus
  26. A. A. E. İbrahim and K. M. El-Sherbeny, “Clarithromycin genotoxicity in mice,” Cytologia, vol. 71, no. 1, pp. 5–10, 2006. View at Publisher · View at Google Scholar · View at Scopus